431
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Clinical diagnostic Next-Generation sequencing: The case of CFTR carrier screening

, , , , &
Pages 374-381 | Received 19 Jul 2014, Accepted 17 Mar 2015, Published online: 15 Apr 2015

References

  • ACOG Committee Opinion No. 486. Update on carrier screening for cystic fibrosis. Obstet Gynecol 2011;117: 1028–31.
  • Cinar C, Yazici C, Ergünsu S, Beyazyürek C, Javadova D, Sağlam Y, Tarcan T, Güney AI. Genetic diagnosis in infertile men with numerical and constitutional sperm abnormalities. Genet Test 2008;12:195–202.
  • Chen H, Ruan YC, Xu WM, Chen J, Chan HC. Regulation of male fertility by CFTR and implications in male infertility. Hum Reprod Update 2012;18:703–13.
  • Field PD, Martin NJ. CFTR mutation screening in an assisted reproductive clinic. Aust N Z J Obstet Gynaecol 2011;51:536–9.
  • Stuppia L, Antonucci I, Binni F, Brandi A, Grifone N, Colosimo A, De Santo M, Gatta V, Gelli G, Guida V, Majore S, Calabrese G, Palka C, Ravani A, Rinaldi R, Tiboni GM, Ballone E, Venturoli A, Ferlini A, Torrente I, Grammatico P, Calzolari E, Dallapiccola B. Screening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programs. Eur J Hum Genet 2005;13:959–64.
  • Costa C, Pruliere-Escabasse V, de Becdelievre A, Gameiro C, Golmard L, Guittard C, Bassinet L, Bienvenu T, Georges MD, Epaud R, Bieth E, Giurgea I, Aissat A, Hinzpeter A, Costes B, Fanen P, Goossens M, Claustres M, Coste A, Girodon E. A recurrent deep-intronic splicing CF mutation emphasizes the importance of mRNA studies in clinical practice. J Cyst Fibros 2011;10:479–82.
  • Tang S, Moonnumakal SP, Stevens B, Douglas G, Mason S, Schmitt ES, Eng CM, Katz M, Fang P. Characterization of a recurrent 3.8kb deletion involving exons 17a and 17b within the CFTR gene. J Cyst Fibros 2013;12:290–4.
  • de Becdelievre A, Costa C, Le Floch A, Legendre M, Jouannic JM, Vigneron J, Bresson JL, Gobin S, Martin J, Goossens M, Girodon E. Notable contribution of large CFTR gene rearrangements to the diagnosis of cystic fibrosis in fetuses with bowel anomalies. Eur J Hum Genet 2010;18:1166–9.
  • Lao O, Andres AM, Mateu E, Bertranpetit J, Calafell F. Spatial patterns of cystic fibrosis mutation spectra in European populations. Eur J Hum Genet 2003;11:385–94.
  • Stoerker J, Goodman TG, Walline HM, Sugalski J 2nd, Holland CA. Evaluation of a BeadXpress Assay for a 151-mutation and variant CFTR screening panel after 11,000 samples: implications for practice. Diagn Mol Pathol 2013;22:144–8.
  • Bickmann JK, Kamin W, Wiebel M, Häuser F, Wenzel JJ, Neukirch C, Stuhrmann M, Lackner KJ, Rossmann H. A novel approach to CFTR mutation testing by pyrosequencing-based assay panels adapted to ethnicities. Clin Chem 20069;55:1083–91.
  • Abou Tayoun AN, Tunkey CD, Pugh TJ, Ross T, Shah M, Lee CC, Harkins TT, Wells WA, Tafe LJ, Amos CI, Tsongalis GJ. A comprehensive assay for CFTR mutational analysis using next-generation sequencing. Clin Chem 2013;59:1481–8.
  • Elliott AM, Radecki J, Moghis B, Li X, Kammesheidt A. Rapid detection of the ACMG/ACOG-recommended 23 CFTR disease-causing mutations using ion torrent semiconductor sequencing. J Biomol Tech 2012;23:24–30.
  • Dörk T, Macek M Jr, Mekus F, Tümmler B, Tzountzouris J, Casals T, Krebsová A, Koudová M, Sakmaryová I, Macek M Sr, Vávrová V, Zemková D, Ginter E, Petrova NV, Ivaschenko T, Baranov V, Witt M, Pogorzelski A, Bal J, Zékanowsky C, Wagner K, Stuhrmann M, Bauer I, Seydewitz HH, Neumann T, Jakubiczka S. Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe. Hum Genet 2000; 106:259–68.
  • Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros 2008;7:450–453.
  • Zvereff VV, Faruki H, Edwards M, Friedman KJ. Cystic fibrosis carrier screening in a North American population. Genet Med 2014;16:539–46.
  • Ramos MD, Masvidal L, Giméne J, Bieth E, Seia M, des Georges M, Armengol L, Casals T. CFTR rearrangements in Spanish cystic fibrosis patients: first new duplication (35kb) characterised in the Mediterranean countries. Ann Hum Genet 2010;74:463–9.
  • Kanavakis E, Efthymiadou A, Strofalis S, Doudounakis S, Traeger-Synodinos J, Tzetis M. Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clin Genet 2003;63:400–9.
  • Kerem E. Atypical CF and CF related diseases. Paediatr Respir Rev 2006;7:S144–6.
  • Martinez B, Heller M, Gaitch N, Hubert D, Burgel PR, Levy P, Girodon E, Bienvenu T. p.Arg75Gln, a CFTR variant involved in the risk of CFTR-related disorders? J Hum Genet 2014;59:206–10.
  • Thauvin-Robinet C, Munck A, Huet F, de Becdelièvre A, Jimenez C, Lalau G, Gautier E, Rollet J, Flori J, Nové-Josserand R, Soufir JC, Haloun A, Hubert D, Houssin E, Bellis G, Rault G, David A, Janny L, Chiron R, Rives N, Hairion D, Collignon P, Valeri A, Karsenty G, Rossi A, Audrézet MP, Férec C, Leclerc J, Georges Md, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Cheillan D, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Izard V, Steffann J, Viville S, Costa C, Drouineaud V, Fauque P, Binquet C, Bonithon-Kopp C, Morris MA, Faivre L, Goossens M, Roussey M, Girodon E; collaborating working group on p.Arg117His. CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders. J Med Genet 2013;50:220–7.
  • Peleg L, Karpati M, Bronstein S, Berkenstadt M, Frydman M, Yonath H, Pras E. The D1152H cystic fibrosis mutation in prenatal carrier screening, patients and prenatal diagnosis. J Med Screen 2011;18:169–72.
  • Bareil C, Thèze C, Béroud C, Hamroun D, Guittard C, René C, Paulet D, Georges Md, Claustres M. UMD-CFTR: a database dedicated to CF and CFTR-related disorders. Hum Mutat 2010;31:1011–9.
  • Lebo RV, Grody WW. Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene. Genet Test 2007;11:32–44.
  • Sikkema-Raddatz B, Johansson LF, de Boer EN, Almomani R, Boven LG, van den Berg MP, van Spaendonck-Zwarts KY, van Tintelen JP, Sijmons RH, Jongbloed JD, Sinke RJ. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat 2013;34: 1035–42.
  • Castellani C, CFTR2 team. CFTR2: how will it help care? Paediatr Respir Rev 2013;14:2–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.